nach oben

Erschienen in:

01.11.2014 | original article

Sex differences in independent factors associated with coronary artery disease

verfasst von: Alois Suessenbacher, MD, Maria Wanitschek, MD, Jakob Dörler, MD, Sabrina Neururer, Matthias Frick, MD, Prof. Otmar Pachinger, MD, Hannes F.W. Alber, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 21-22/2014

Einloggen, um Zugang zu erhalten

Summary

Background

Women undergoing coronary angiography (CA) due to chest pain are more likely to present with less extensive coronary artery disease (CAD) than men, which might be attributed to different effects of cardiovascular risk factors on coronary atherogenesis between sexes. The aim of the present study was to evaluate sex differences in independent factors associated with obstructive and non-obstructive CAD in a large consecutive cohort of patients undergoing elective CA.

Methods

Data from 7819 patients (2653 women and 5184 men), including cardiovascular risk factors, clinical presentation, CAD severity and treatment decisions were analysed.

Results

Women were older than men (65 ± 11 vs. 63 ± 11 years, p < 0.001); low-density lipoprotein cholesterol (LDL; 125 ± 38 vs. 122 ± 37 mg/dL, p < 0.001) and high-density lipoprotein cholesterol (HDL) cholesterol levels (62 ± 18 vs. 51 ± 15 mg/dL, p < 0.001) were higher in women; and smokers were more frequently men (14.4 vs. 20.1 %, p < 0.001). Men more frequently had an obstructive CAD (41.1 vs. 65.6 %, p < 0.001). Multivariable analyses revealed age, HDL cholesterol, hypercholesterolaemia, diabetes mellitus, arterial hypertension and a positive family history being associated with obstructive CAD in both sexes, whereas smoking was independently associated with obstructive CAD only in women. The association of hypercholesterolaemia with obstructive CAD was stronger in men. For non-obstructive CAD, no sex-specific associated factors could be identified.

Conclusion

The impact of smoking and hypercholesterolaemia on coronary atherosclerosis is different between women and men. This might be taken into account when planning individual interventions to reduce cardiovascular risk.

Vorheriger Artikel Off-pump myocardial revascularization attenuates endothelin-1 expression in systemic, pulmonary, and coronary circulation

Nächster Artikel Serum H-FABP levels in patients with hypothyroidism

Mancini GB, Bates ER, Maron DJ, et al. Quantitative results of baseline angiography and percutaneous coronary intervention in the COURAGE trial. Circ Cardiovasc Qual Outcomes. 2009;2(4):320–7.PubMedCrossRef

Jong P, Mohammed S, Sternberg L. Sex differences in the features of coronary artery disease of patients undergoing coronary angiography. Can J Cardiol. 1996;12(7):671–7.PubMed

Bugiardini R, Bairey Merz CN. Angina with “normal” coronary arteries: a changing philosophy. JAMA. 2005;293(4):477–84.PubMedCrossRef

Humphries KH, Pu A, Gao M, et al. Angina with “normal” coronary arteries: sex differences in outcomes. Am Heart J. 2008;155(2):375–81.PubMedCrossRef

Judkins MP. Selective coronary arteriography. I. A percutaneous transfemoral technic. Radiology. 1967;89(5):815–24.PubMedCrossRef

Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.PubMedCrossRef

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Suppl. 1):S5–20.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–97.CrossRef

Campeau L. The Canadian Cardiovascular Society grading of angina pectoris revisited 30 years later. Can J Cardiol. 2002;18(4):371–9.PubMed

10.

Chiamvimonvat V, Sternberg L. Coronary artery disease in women. Can Fam Physician. 1998;44:2709–17.

11.

Daly C, Clemens F, Lopez Sendon JL, et al. Gender differences in the management and clinical outcome of stable angina. Circulation. 2006;113(4):490–8.PubMedCrossRef

12.

Shaw LJ, Shaw RE, Merz CN, et al. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation. 2008;117(14):1787–801.PubMedCrossRef

13.

Kreatsoulas C, Natarajan MK, Khatun R, et al. Identifying women with severe angiographic coronary disease. J Intern Med. 2009;268(1):66–74.PubMed

14.

Anand SS, Islam S, Rosengren A, et al. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J. 2008;29(7):932–40.PubMedCrossRef

15.

Ferrari R, Abergel H, Ford I, et al. Gender- and age-related differences in clinical presentation and management of outpatients with stable coronary artery disease. Int J Cardiol. 2012;167:2938–43.

16.

Prescott E, Osler M, Andersen PK, et al. Mortality in women and men in relation to smoking. Int J Epidemiol. 1998;27(1):27–32.PubMedCrossRef

17.

Warren CW, Jones NR, Peruga A, et al. Global youth tobacco surveillance, 2000–2007. MMWR Surveill Summ. 2008;57(1):1–28.PubMed

18.

Global Youth Tabacco Survey Collaborative Group. Tobacco use among youth: a cross country comparison. Tob Control. 2002;11(3):252–70.CrossRef

19.

Currie C, Zanotti C, Morgan A, et al. Social determinants of health and well-being among young people. Health Behaviour in School-aged Children (HBSC) study: international report from the 2009/2010 survey, WHO Regional Office for Europe, Copenhagen. Health Policy Child Adolesc 2012;6:141–147.

20.

Shaw LJ, Bairey Merz CN, Pepine CJ, et al. Insights from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) study: part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol. 2006;47(3 Suppl.):S4–20.PubMedCrossRef

21.

Petretta M, Costanzo P, Perrone-Filardi P, et al. Impact of gender in primary prevention of coronary heart disease with statin therapy: a meta-analysis. Int J Cardiol. 2010;138(1):25–31.PubMedCrossRef

22.

Alber HF, Frick M, Suessenbacher A, et al. Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease—a randomized, placebo-controlled study. Am Heart J. 2006;151(1):139.PubMedCrossRef

23.

Alber HF, Duftner C, Wanitschek M, et al. Neopterin, CD4+ CD28− lymphocytes and the extent and severity of coronary artery disease. Int J Cardiol. 2009;135(1):27–35.PubMedCrossRef

24.

Alber HF, Wanitschek M, Duftner C, et al. Neopterin: marker of coronary artery disease activity, severity and/or extent in patients with clinically stable angina? Int J Cardiol. 2010;144(1):75–6.CrossRef

25.

Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342(12):836–43.PubMedCrossRef

26.

Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2004;109(7):837–42.PubMedCrossRef

27.

Alber HF, Wanitschek MM, de Waha S, et al. High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography. Eur J Clin Invest. 2008;38(6):372–80.PubMedCrossRef

28.

Khor LL, Muhlestein JB, Carlquist JF, et al. Sex- and age-related differences in the prognostic value of C-reactive protein in patients with angiographic coronary artery disease. Am J Med. 2004;117(9):657–64.PubMedCrossRef

29.

Garcia-Moll X, Zouridakis E, Cole D, et al. C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. Eur Heart J. 2000;21(19):1598–606.PubMedCrossRef

30.

Qasim AN, Budharaju V, Mehta NN, et al. Gender differences in the association of C-reactive protein with coronary artery calcium in type-2 diabetes. Clin Endocrinol (Oxf). 2010;74(1):44–50.CrossRef

31.

Lakoski SG, Cushman M, Blumenthal RS, et al. Implications of C-reactive protein or coronary artery calcium score as an adjunct to global risk assessment for primary prevention of CHD. Atherosclerosis. 2007;193(2):401–7.PubMedCrossRef

32.

Granot M, Goldstein-Ferber S, Azzam ZS. Gender differences in the perception of chest pain. J Pain Symptom Manage. 2004;27(2):149–55.PubMedCrossRef

33.

Bosner S, Haasenritter J, Hani MA, et al. Gender bias revisited: new insights on the differential management of chest pain. BMC Fam Pract. 2011;12:45.

34.

Hess EP, Perry JJ, Calder LA, et al. Sex differences in clinical presentation, management and outcome in emergency department patients with chest pain. CJEM. 2010;12(5):405–13.PubMed

35.

King KM, Ghali WA, Faris PD, et al. Sex differences in outcomes after cardiac catheterization: effect modification by treatment strategy and time. JAMA. 2004;291(10):1220–5.PubMedCrossRef

36.

Petticrew M, McKee M, Jones J. Coronary artery surgery: are women discriminated against? BMJ. 1993;306(6886):1164–6.PubMedCentralPubMedCrossRef

37.

Ghali WA, Faris PD, Galbraith PD, et al. Sex differences in access to coronary revascularization after cardiac catheterization: importance of detailed clinical data. Ann Intern Med. 2002;136(10):723–32.PubMedCrossRef

38.

Guru V, Fremes SE, Tu JV. Time-related mortality for women after coronary artery bypass graft surgery: a population-based study. J Thorac Cardiovasc Surg. 2004;127(4):1158–65.PubMedCrossRef

39.

Gitt AK, Bueno H, Danchin N, et al. The role of cardiac registries in evidence-based medicine. Eur Heart J. 2010;31(5):525–9.PubMedCrossRef

Titel: Sex differences in independent factors associated with coronary artery disease
verfasst von: Alois Suessenbacher, MD
Maria Wanitschek, MD
Jakob Dörler, MD
Sabrina Neururer
Matthias Frick, MD
Prof. Otmar Pachinger, MD
Hannes F.W. Alber, MD
Publikationsdatum: 01.11.2014
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 21-22/2014
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-014-0602-9

Springer Medizin Österreich

Summary

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 21-22/2014

HerzMobil Tirol network: rationale for and design of a collaborative heart failure disease management program in Austria

Mitteilungen der Gesellschaft der Ärzte in Wien

Atrial fibrillation: state of the art

Serum H-FABP levels in patients with hypothyroidism

Researcher of the month

Off-pump myocardial revascularization attenuates endothelin-1 expression in systemic, pulmonary, and coronary circulation